(With Adobe DRM, readable with Adobe Digital Editions for PCs and Macs, and on most mobile devices except Kindle)
Successfully fighting cancer starts with understanding how it begins. This thoroughly revised 3rd Edition explores the scientific basis for our current understanding of malignant transformation and the pathogenesis and treatment of cancer. A team of leading experts thoroughly explain the molecular biologic principles that underlie the diagnostic tests and therapeutic interventions now being used in clinical trials and practice. Incorporating cutting-edge advances and the newest research, the book provides thorough descriptions of everything from molecular abnormalities in common cancers to new approaches for cancer therapy. A new full-color format expedites reference, and now as an Expert Consult title, it enables you to conveniently search the entire text online, download all of the book’s images for your personal use, and review periodic updates.
Features numerous descriptions of the latest clinical strategies—helping you to understand and take advantage of today’s state-of-the-art biotechnology advances.
Offers online access the book's complete contents—fully searchable—along with periodic updates, and artwork from the text for your personal use.
Features sweeping updates throughout, including molecular targets for the development of anti-cancer drugs, gene therapy, and vaccines...keeping you on the cutting edge of your specialty.
Offers a new, more user-friendly full-color format so the information that you need is easier to find.
Presents abundant figures—all redrawn in full color—illustrating major concepts for easier comprehension.
“Each chapter is written by a well-known authority in the respective field...An outstanding achievement.” – Journal of the National Cancer Institute, review of the 1st edition
“Easy to read but contains a wealth of information...achieves its goal of being both educational and exhaustive.” – The Cancer Bulletin, review of the 1st edition
By John Mendelsohn, MD, President and Professor of Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX; Peter M. Howley, MD, Professor and Chairman, Department of Pathology, Harvard Medical School, Boston, MA; Mark A. Israel, MD, Director, Norris Cotton Cancer Center; Professor of Pediatrics and Genetics, Dartmouth Medical School, Hanover, NH; Joe W. Gray, PhD, Director, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA; and Craig B. Thompson, MD, Director, Abramson Cancer Center; Professor of Medicine, University of Pennsylvania, Philadelphia, PA
Elsevier is a leading publisher of health science books and journals, helping to advance medicine by delivering superior education, reference information and decision support tools to doctors, nurses, health practitioners and students. With titles available across a variety of media—print, online and handheld, we are able to supply the information you need in the most convenient format.